Promotions & Moves

Selexis SA Appoints Hoffmann-Hecht CBO

Dr. Hoffmann-Hecht will serve on the executive leadership team and will report to Selexis CEO Dirk Lange.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Selexis SA, a JSR Life Sciences company, has named Roland Hoffmann-Hecht, Ph.D., as its new chief business officer. As a member of the company’s executive leadership team, Dr. Hoffmann-Hecht will be responsible for all corporate and business development activities and will report to Selexis Chief Executive Officer Dirk Lange.   Dr. Hoffmann-Hecht joined the company from Polpharma Biologics, where he was head of business development, CDMO Europe. Previously, he was chief customer officer at CDM...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters